|
2025
|
Invention
|
Azine-based compounds as par-2 inhibitors and therapeutic uses thereof. The present invention pro... |
|
|
Invention
|
Combinations of par2 inhibitors and immune checkpoint inhibitors for the treatment of cancer. The... |
|
2024
|
Invention
|
5-azaindazole derivatives as adenosine receptor antagonists.
The present invention relates to no... |
|
|
Invention
|
Anti-ccr8 monoclonal antibodies and their therapeutic use. The present invention relates to a mon... |
|
2023
|
Invention
|
Novel par-2 inhibitors.
The present invention provides novel compounds of formula (I) and pharma... |
|
|
Invention
|
Novel par-2 inhibitors. The present invention provides novel compounds of formula (I) and pharmac... |
|
2022
|
Invention
|
Bezimidazole derivatives as adenosine receptor antagonists.
The invention relates to benzimidazo... |
|
2020
|
Invention
|
Prostaglandin e2 (pge2) ep4 receptor antagonists.
The present invention relates to novel compoun... |
|
|
Invention
|
Prostaglandin e2 (pge2) ep4 receptor antagonists. The present invention relates to novel compound... |
|
|
Invention
|
5-heteroaryl-pyridin-2-amine compounds as neuropeptide ff receptor antagonists.
The present inve... |
|
|
Invention
|
5-heteroaryl-pyridin-2-amine confounds as neuropeptide ff receptor antagonists. The present inven... |
|
|
Invention
|
Thiazolopyridine derivatives as adenosine receptor antagonists. The invention relates to thiazolo... |
|
2019
|
Invention
|
5-azaindazole derivatives as adenosine receptor antagonists. 2B adenosine receptor antagonists, a... |
|
|
G/S
|
Chemicals, excluding research reagents,used in the biological, biotechnological, medical, pharmac... |
|
|
Invention
|
Substituted quinazolinone derivatives and their use as positive allosteric modulators of mglur4. ... |
|
|
Invention
|
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group ii... |
|
2018
|
G/S
|
Produits chimiques et biologiques, sous la forme de molécules isolées, à savoir petites molécules... |
|
|
Invention
|
Systems and methods for the assessment of g-protein activation.
Systems and methods for the moni... |
|
|
Invention
|
Systems and methods for the assessment of g-protein activation. Systems and methods for the monit... |
|
|
G/S
|
Chemical and biological products for use in the medical and scientific research industry, namely,... |
|
|
G/S
|
Chemical additives used in the biotechnology and pharmaceutical industries; Chemicals used for bi... |
|
|
G/S
|
Agents thérapeutiques, chimiques, biologiques, naturels, nommément : produits pharmaceutiques pou... |
|
|
G/S
|
Chemical or biological or natural preparations used in the healthcare industry or in research, in... |
|
|
G/S
|
Chemicals, or biological or natural preparations used in the healthcare or research industry. Res... |
|
|
G/S
|
Chemicals or biological or natural products, in the form of isolated molecules, for use in the he... |
|
|
Invention
|
Quinoxaline derivatives as adenosine receptor antagonists. The invention relates to quinoxaline d... |
|
|
Invention
|
Benzimidazole derivatives as adenosine receptor antagonists. The invention relates to benzimidazo... |
|
|
Invention
|
Substituted heterocyclic compounds as allosteric modulators of group ii metabotropic glutamate re... |
|
|
G/S
|
[ Chemicals used in the biological, biotechnological, medical, pharmaceutical, and veterinary ind... |
|
2016
|
Invention
|
Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metab... |
|
2014
|
G/S
|
Agents thérapeutiques, chimiques, biologiques, naturels, destinés au traitement d'indications imp... |
|
|
G/S
|
[ Chemical and biological products for use in the medical and scientific research industry, namel... |
|
|
G/S
|
Chemicals, or biological or natural preparations used in the healthcare or research industry. Sci... |
|
2010
|
Invention
|
Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptor... |
|
|
Invention
|
Adenosine receptor ligands and uses thereof. 2A receptors could be beneficial. |
|
|
Invention
|
New adenosine receptor ligands and uses thereof. The present invention provides new compounds wit... |
|
2009
|
G/S
|
Chemical or biological or natural preparations, in the form of isolated molecules used in the hea... |
|
|
G/S
|
Chemical or biological or natural preparations used in the healthcare industry or research, in pa... |
